首页> 外文期刊>Pediatric clinics of North America >Vancomycin resistance in the enterococcus. Relevance in pediatrics.
【24h】

Vancomycin resistance in the enterococcus. Relevance in pediatrics.

机译:肠球菌对万古霉素耐药。与儿科有关。

获取原文
获取原文并翻译 | 示例
       

摘要

Enterococci are nosocomial pathogens intrinsically resistant to a variety of commonly used antimicrobial agents. The frequent use of antimicrobial agents such as cephalosporins has been associated with the increased isolation of enterococci in pediatric hospitals. In addition to their intrinsic resistance traits, the enterococci have rapidly accumulated a variety of acquired resistance determinants. Strains that are resistant to all currently available antibiotics are now being isolated from infected children. The threat of untreatable enterococcal infection and the possibility that vancomycin resistance may spread from the enterococci to the more virulent pneumococci or staphylococci argue for vigilant surveillance for resistant strains, isolation and barrier precautions for infected patients, increased research into the mechanisms of resistance, and a reinvigorated effort to identify new classes of antimicrobial agents.
机译:肠球菌是对多种常用抗菌剂具有内在抵抗力的医院病原体。儿科医院频繁使用抗菌药物(如头孢菌素)与增加肠球菌的隔离有关。除其固有的抗药性外,肠球菌还迅速积累了多种获得性抗药性决定因素。目前正在从受感染的儿童中分离出对所有目前可用的抗生素具有抗性的菌株。不可治愈的肠球菌感染的威胁以及万古霉素耐药性可能从肠球菌传播到更强毒的肺炎球菌或葡萄球菌的可能性,要求对耐药菌株进行警惕监测,对感染患者进行隔离和隔离预防,增加对耐药机制的研究,以及重新确定新类别的抗菌剂的努力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号